SCHEMBL8295489

SCHEMBL8295489

Cc1cc2c(Cl)cccc2cc1C(N)NO

nearest known ligand 0.34

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 5/20 0.34
CYP2A6 P11509 2/20 0.34
CYP3A4 P08684 2/20 0.33
CYP2D6 P10635 2/20 0.33
NFKB1 P19838 1/20 0.33
PNMT P11086 1/20 0.33
LMNA P02545 2/20 0.33
ALDH1A1 P00352 1/20 0.33
GLA P06280 1/20 0.33
NR4A2 P43354 3/20 0.32
GAA P10253 1/20 0.31
HDAC3 O15379 2/20 0.31
HDAC4 P56524 2/20 0.31
HDAC1 Q13547 2/20 0.31
HDAC7 Q8WUI4 2/20 0.31
HDAC2 Q92769 2/20 0.31
HDAC10 Q969S8 2/20 0.31
HDAC11 Q96DB2 2/20 0.31
HDAC8 Q9BY41 2/20 0.31
HDAC6 Q9UBN7 2/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8295480 0.83 CYP1A2 (0.37) CYP1A2CYP2A6CYP3A4CYP2D6NFKB1
SCHEMBL8295503 0.83 CYP1A2 (0.39) CYP1A2CYP2A6CYP3A4CYP2D6NFKB1
SCHEMBL8295481 0.79 CYP2D6 (0.34) CYP1A2CYP2A6CYP3A4CYP2D6
SCHEMBL8287999 0.73 CYP1A2 (0.50) CYP1A2CYP2A6CYP3A4ALDH1A1NR4A2
SCHEMBL8268455 0.71 CYP1A2 (0.48) CYP1A2CYP2A6CYP3A4ALDH1A1NR4A2
SCHEMBL22743919 0.71 HSD17B1 (0.46) CYP1A2CYP2A6CYP3A4CYP2D6ALDH1A1
SCHEMBL14350356 0.70 CYP1A2 (0.36) CYP1A2CYP2A6CYP3A4LMNANR4A2
SCHEMBL9881355 0.68 CYP1A2 (0.41) CYP1A2CYP2A6ALDH1A1NR4A2GAA
SCHEMBL9881352 0.68 KDM4E (0.47) CYP3A4ALDH1A1GAANOTUM
SCHEMBL8268459 0.67 CYP1A2 (0.43) CYP1A2CYP2A6CYP3A4CYP2D6ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7338963-B2 Lactam-containing compounds and derivatives thereof as factor Xa inhibitors BRISTOL-MYERS SQUIBB COMPANY (US) 2008-03-04 US disclosed
WO-2004108892-A2 1,1-DISUBSTITUTEDCYCLOALKYL-, GLYCINAMIDYL-, SULFONYL-AMIDINO-, AND TETRAHYDROPYRIMIDINYL-CONTAINING DIAMINOALKYL, β-AMINOACIDS, α-AMINOACIDS AND DERIVATIVES THEREOF AS FACTOR XA INHIBITORS BRISTOL-MYERS SQUIBB COMPANY (US) 2004-12-16 WO disclosed
WO-2004083174-A2 SULFONYL-AMIDINO CONTAINING AND TETRAHYDROPYRIMIDINO CONTAINING COMPOUNDS AS FACTOR XA INHIBITORS BRISTOL-MYERS SQUIBB COMPANY (US) 2004-09-30 WO disclosed